Loading organizations...
PMT Corporation specializes in the research, development, and manufacturing of specialty medical products, devices, and instruments. Their portfolio spans Plastic and Reconstructive Surgery, Neurosurgery, Orthopedic Medicine, and Gastrointestinal Endoscopy. The company is known for offerings such as AccuSpan® and Integra® Tissue Expanders, Cervical traction Halo systems, and Cortac® and Depthalon® epilepsy electrodes, alongside Permark® micropigmentation machines.
Established in 1979, PMT Corporation began its journey with a focus on addressing specific needs within the medical field. The company has grown from its inception to become an internationally certified distributor, emphasizing the development and quality manufacturing of medical devices. This foundational commitment to enhancing clinical practice through specialized tools has guided its operational trajectory.
PMT Corporation serves a global customer base of medical professionals, including plastic surgeons, neurosurgeons, and orthopedic specialists, distributing its products in over 30 countries. The company commits to providing these customers with high-quality products and comprehensive service. Its vision centers on continuously advancing medical technologies to support better patient outcomes and clinical efficiency across its specialized therapeutic areas.
PMT has 1 tracked investment across 1 company. The latest tracked deal is $38.0M Series D in EFFECT Photonics in March 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 25, 2024 | EFFECT Photonics | $38.0M Series D | Vincent Kamphorst | PM Equity Partner |